Dr Reddys Laboratories Ltd

Dr Reddy's Labs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Dr Reddys Laboratories Ltd

₹ 1,230 0.65%
23 May - close price
drreddys.com BSE: 500124 NSE: DRREDDY
About

Dr. Reddy's Laboratories Ltd is a leading India-based pharmaceutical company which offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical services (CPS), generics, biosimilars and differentiated formulations.

Key Points

Global Generics Segment (~83% of revenues in FY22)
Co. offers 400+ high-quality generic drugs, keeping costs reasonable by leveraging its integrated operations. The company benefits from its expertise in active ingredients, product development skills, a keen understanding of regulations and intellectual property rights & streamlined supply chain. [1]
Top revenue contributors of the segment are nervous system drugs (14%), gastrointestinal (13%) & anti-infective (10%) [2]
In FY22, co. filed 7 new ANDA’s with US FDA [3]

Website BSE NSE
  • Market Cap ₹ 1,02,646 Cr.
  • Current Price ₹ 1,230
  • High / Low ₹ 1,421 / 1,020
  • Stock P/E 19.2
  • Book Value ₹ 346
  • Dividend Yield 0.65 %
  • ROCE 25.6 %
  • ROE 20.2 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has been maintaining a healthy dividend payout of 17.8%

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Part of Nifty 50 BSE 500 BSE Healthcare BSE 100 BSE 200

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
3,669 3,631 4,880 3,898 4,554 5,437 4,839 4,103 5,105 5,841 6,696 5,015 5,563
2,999 3,051 3,078 3,222 3,493 3,210 3,210 3,447 3,726 3,888 3,975 3,823 4,120
Operating Profit 670 580 1,803 675 1,061 2,228 1,629 656 1,379 1,953 2,722 1,192 1,443
OPM % 18% 16% 37% 17% 23% 41% 34% 16% 27% 33% 41% 24% 26%
115 403 118 51 115 234 223 228 213 218 208 235 414
Interest 13 10 2 3 3 4 6 6 6 7 28 43 31
Depreciation 205 222 226 239 237 237 246 246 246 250 260 265 264
Profit before tax 567 752 1,693 485 937 2,220 1,601 632 1,339 1,914 2,641 1,119 1,562
Tax % 26% 34% 34% 33% 28% 26% 25% 25% 23% 26% 29% 24% 23%
420 500 1,116 325 672 1,639 1,193 475 1,035 1,417 1,882 849 1,201
EPS in Rs 5.04 6.00 13.41 3.90 8.08 19.69 14.30 5.70 12.41 16.99 22.56 10.18 14.39
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
9,728 10,011 10,292 9,720 9,359 10,626 11,850 13,349 14,405 16,962 19,484 23,115
6,950 7,608 8,219 7,899 7,990 8,290 8,967 10,212 11,803 12,724 13,557 15,734
Operating Profit 2,778 2,403 2,073 1,820 1,370 2,336 2,883 3,137 2,602 4,238 5,926 7,382
OPM % 29% 24% 20% 19% 15% 22% 24% 24% 18% 25% 30% 32%
135 211 317 516 164 202 730 801 474 568 862 1,003
Interest 78 64 64 57 63 57 48 47 38 17 22 110
Depreciation 380 490 650 735 774 781 789 835 814 923 976 1,039
Profit before tax 2,454 2,060 1,677 1,544 697 1,701 2,776 3,056 2,224 3,866 5,791 7,236
Tax % 21% 18% 18% 10% 19% 25% -6% 28% 27% 32% 25% 26%
1,933 1,679 1,374 1,384 567 1,277 2,938 2,186 1,623 2,613 4,342 5,349
EPS in Rs 22.73 19.71 16.11 16.70 6.83 15.38 35.36 26.29 19.51 31.38 52.06 64.11
Dividend Payout % 16% 20% 25% 24% 59% 26% 14% 19% 31% 26% 15% 12%
Compounded Sales Growth
10 Years: 9%
5 Years: 14%
3 Years: 17%
TTM: 19%
Compounded Profit Growth
10 Years: 13%
5 Years: 13%
3 Years: 49%
TTM: 25%
Stock Price CAGR
10 Years: 6%
5 Years: 10%
3 Years: 13%
1 Year: 5%
Return on Equity
10 Years: 14%
5 Years: 15%
3 Years: 18%
Last Year: 20%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 85 85 85 83 83 83 83 83 83 83 83 83
Reserves 9,244 10,549 11,993 11,518 11,725 12,601 15,109 16,900 18,253 20,391 24,157 28,773
2,666 3,126 3,085 2,355 2,589 1,065 1,457 1,214 2,205 51 793 3,493
2,513 2,696 2,422 2,491 2,704 2,499 2,827 3,431 3,954 4,850 5,326 5,941
Total Liabilities 14,508 16,456 17,585 16,447 17,100 16,248 19,476 21,630 24,496 25,375 30,359 38,291
2,748 3,249 4,438 4,842 4,717 4,683 4,434 5,844 6,150 7,195 7,589 8,273
CWIP 576 488 616 540 675 400 412 901 1,200 924 1,211 2,156
Investments 2,806 3,862 5,076 3,102 3,636 3,934 5,486 4,649 4,937 7,440 7,321 13,194
8,377 8,856 7,455 7,963 8,072 7,231 9,145 10,235 12,208 9,815 14,239 14,668
Total Assets 14,508 16,456 17,585 16,447 17,100 16,248 19,476 21,630 24,496 25,375 30,359 38,291

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
906 1,786 2,747 1,016 1,539 2,762 1,839 3,514 1,339 5,053 3,450 4,225
-874 -2,031 -1,919 1,430 -1,180 -546 -1,689 -1,454 -1,990 -3,403 -3,429 -5,698
28 189 -693 -2,582 -304 -2,223 -224 -794 506 -2,697 68 1,591
Net Cash Flow 60 -56 135 -135 54 -8 -74 1,266 -146 -1,047 89 118

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 171 172 138 165 164 128 143 112 125 92 87 94
Inventory Days 233 223 234 256 258 242 224 250 242 219 291 275
Days Payable 123 93 99 110 147 124 109 118 121 127 148 120
Cash Conversion Cycle 281 302 273 311 274 246 257 243 247 184 230 250
Working Capital Days 181 179 156 182 180 143 148 128 144 95 144 162
ROCE % 23% 16% 12% 11% 5% 12% 19% 15% 12% 19% 25% 26%

Shareholding Pattern

Numbers in percentages

1 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
26.71% 26.71% 26.69% 26.69% 26.69% 26.66% 26.65% 26.65% 26.65% 26.64% 26.64% 26.64%
25.87% 26.26% 27.29% 27.25% 26.99% 28.19% 28.62% 29.13% 27.68% 27.53% 26.85% 25.75%
25.18% 24.69% 23.38% 23.05% 21.99% 21.04% 18.65% 18.31% 20.72% 21.48% 22.89% 25.63%
21.96% 22.06% 22.36% 22.78% 24.11% 23.93% 25.89% 25.73% 24.78% 24.20% 23.46% 21.69%
0.28% 0.27% 0.25% 0.22% 0.21% 0.18% 0.18% 0.17% 0.17% 0.16% 0.16% 0.29%
No. of Shareholders 2,55,3002,59,2712,46,7882,32,7152,46,7692,43,4452,57,7942,55,5002,67,6943,10,4034,03,6694,59,605

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls